Relative risk of malignant tumors in analgesic abusers

Clinical Nephrology

Volumn 51, Issue 2, 1999, Pages 67-72

  Bucher, C ^b   Jordan, P ^b   Nickeleit, V ^b   Torhorst, J ^b   Mihatsch, M J ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

^b NONE

Author keywords

Analgesic abuse; Aspirin; Autopsy study; Cancer risk

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; CAFFEINE; CODEINE; PHENACETIN;

ADULT; AGED; ANALGESIC AGENT ABUSE; ARTICLE; CANCER; CANCER RISK; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE;

AGED; ANALGESICS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; FEMALE; HUMANS; MALE; NEOPLASMS; ODDS RATIO; RISK FACTORS; SUBSTANCE-RELATED DISORDERS;

EID: 0032970912     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Amtonioli DA 1994 Precursors of gastric carcinoma: a critical review with a brief description of farcy (curable) gastric cancer. Hum Pathol 25: 995-1001
2. Bengtsson U. Johansson S, Angervall L 1978 Malignances of the urinary tract and their relation to analgesic abuse. Kidney Int 13: 107-113
3. Burry AF 1967 The evolution of analgesic nephropathy. Nephron 5: 185-188
4. Craven PA, De Rubertis FR 1992 Effects of aspirine on 1,2-dimethylhydrazin induced colonic carcinogenesis. Carcinogenesis 13: 541-546
5. Drago JR, Murray C 1984 Control of metastases in the Nb rat prostatic adeno-carcinoma model. J Androl 5: 265-268
6. Gann PH, Manson JE, Buring JE, Hennekens CH 1993 Low dose aspirin and incidence ot colorectal tumors in a randomized trial. J Natl Cancer Inst 85: 1220-1224
7. Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Ascherio A, Willett WC 1994 Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Ann Intern Med 121: 241-246
8. Giovannuci E, Egan KM, Hunter DJ, Stampfer MJ, Colditz GA, Willett WC, Speizer FE 1995 Aspirin and the risk of colorectal cancer in women. N Engl J 333: 609-612
9. Greenberg ER, Baron JA, Freeman DH, Mandel JS, Haile R 1986 Reduced risk of large bowel adenomas in patients with rheumatoid arthritis. J. Reumatology 13: 522-526
10. Gridley G, McLaughlin JK, Ekbom A et al 1993 Incidence of cancer among patients with rheumatoid arthrits. J Natl Cancer Inst 85: 307-311
11. Heath CW jr, Thun MJ, Greenberg ER, Levin B, Marnett LJ 1994 Nonsteroidal anti-inflammatory drugs and human cancer: report of an interdisciplinary research workshop. Cancer 74: 1885-1888
12. Hofer HO, Mihatsch MJ, Torhorst J, Rist R, Rutishauser G, Zollinger HU 1979 Veränderungen der ableitenden Harnwege bei Analgetika-(Phenacetin-)Abusus. Urologie 19: 131-139
13. Jalbert G, Castonguay A 1992 Effects of NSAIDs on NNK-induced pulmonary and gastric tumorgenesis in A/J mice. Cancer Lett. 66: 21-28
14. Kune GA, Kune S, Watson LF 1988 Colorectal cancer risk, chronic illness, operations and medications: Case control results from the Melbourne colorectal cancer study. Cancer Res 48: 4399-4404
15. Kunze E, Mohlmann K 1985 Proliferation-stimulating effect of phenacetin on the urothelium and papillary epithelium of rats. Urol Int 38: 223
16. Lala K, Parhar S 1993 Eradication of spontaneous and experimental adeno-carcinoma metastasis with chronic indomethacin and intermittent IL-2-therapy. Int J Cancer 54: 677-684
17. Lundegardh G, Adam HO, Helmick C, Zack M, Meirik O 1983 Stomach cancer after partial gastrectomy for benign ulcer disease. N Engl J Med 19: 195-200
18. Lynch NR, Castes M, Astoin M, Salomon J-C 1978 Mechanism of inhibition of tumor growth by aspirin and indomethacin. Br J Cancer 38: 503-511
19. Mantel N, Haenszel W 1959 The Mantel-Haenszel-Method. J Nat Cane Inst 22: 719-748
20. Marnett LJ 1992 Aspirin and the potential role of prostaglandins in colon cancer. Cancer Res 52: 5575-5589
21. Metha RG, Moon RC 1991 Characterization of effective chemopreventive agents in mammary gland in vitro using a initiation-promotion protocol. Anticancer Res 11:593-596
22. Mihatsch MJ, Knusli C 1982 Phenacetine abuse and malignant tumors. Klin Wschr 60: 1339
23. Mihatsch MJ, Torhorst J, Amsler B, Zollinger HU 1978 Capillarosclerosis of the lower urinary tract in analgesic (phenacetin) abuse. An electron-microscopic study. Virch Arch A Path Anat Histol 381: 41-47
24. Mihatsch MJ, Torhost J, Steinmann E, Hofer H, Stikkelberger M, Bianchi L, Berneis K, Zollinger HU 1979a The morphologic diagnosis of analgesic (phenacetin) abuse. Path Res Pract 164: 68-79
25. Mihatsch MJ, Gloor F, Torhorst J, Rist R, Rutishauser G, Zollinger HU 1979b Die Kapillarosklerose der ableitenden Harnwege - ein pathognomonischer Befund beim Analgetika-(Phenacetin-) Abusus. Verh Deutsch Ges Path 63: 540
26. Mihatsch MJ, Hofer HO, Gutzwiler F, Brunner FP, Zollinger HU 1980a Phenacetinabusus I: Haufigkeit. ProKopf-Verbrauch und Folgekosten. Schweiz Med Wschr 110: 108-115
27. Mihatsch MJ, Manz T, Knüsli C, Hofer HO, Rist M, Guetg R, Rutishauser G, Zollinger HU 1980b Phenacetinabusus III: Maligne Harnwegstumoren bei Phenacetin-abusus in Basel 1963-1977. Schweiz Med Wschr 110: 225-264
28. Mihatsch MJ, Kernen R, Zollinger HU 1982 Phenacetina-busus VI: Eine Autopsiesiudie mit besonderer Berucksichtigung extrarenaler Befunde. Schweiz Med Wschr 112: 1883-1888
29. Mihatsch MJ, Hofer HO, Gudat F., Knusli C, Torhorst J, Zollinger HU 1983 Capillarosclerosis of the urinary tract and analgesic nephropathy. Clin Nephrol 112: 1468
30. Mihatsch MJ, Brunner FB, Gloor FJG 1994 Analgesic nephropathy and papillary necrosis. In: Tischer CC, Brenner BM (eds): Renal Pathology. Lippincott, Philadelphia, pp 905-936
31. Moorghen M, Ince P, Finney KJ, Sunter JP, Appleton DR, Watson AJAs 1988 Protective effect of sundlinac against chemically induced primary colonic tumors in mice. J. Pathol. 156: 341-347
32. Nanra RS, Stewart-Taylor J, de Leon AH, White K 1978 Analgesic nephropathy: etiology, clinical syndrome and clinic pathologic relations in Australia. Kidney Int 113: 79-92
33. Pagannini-Hill A, Chao A, Ross RK, Henderson BE 1989 Aspirin use and chronic diseases: a cohort study of the elderly. BMJ 229: 1247-1250
34. Pagannini-Hill A, Hsu G, Ross RK, Henderson BE 1991 Aspirin use and incidence of large bowel cancer in a California retirement community. J Natl Cancer Inst 83: 1182-1188
35. Peleg II, Maibach HT, Brown SH, Wilcox MC 1994 Aspirin and nonsteroidal anti-inflammatory drug use and the risk of subsequent colorectal cancer. Arch Intern Med 154: 394-399
36. Pollard M., Luckert PH 1983 Prolonged antitumor effect of indomethacin on autoch-tonous intestinal tumors in rats. J Natl Cancer Inst 70: 1103-1105
37. Reddy BS, Marjuana H, Kellof G 1987 Dose-related inhibition of colon carcinogenesis by dietary piroxicam, a nonsteroidal antiinflammatory drug, during different stages of rat colon tumor development. Cancer Res 47: 5340-5346
38. Reddy BS, Rao CV, Rivenson A, Kellof C 1993 Inhibitory effect of Aspirine on 1,2 azoxymethane-induced colon carcinogenesis in F344 rats. Carcinogenesis 14: 1493-1497
39. Rosenberg L, Palmer JR, Zauber AG, Warshauer ME, Stolley PD, Shapiro S 1991 A Hypothesis: Nonsteroidal anti-inflymmatory drug use and the risk of large-bowel cancer. J Natl Cancer Inst 83: 355-358
40. Schreinemachers DM, Everson RB 1994 Aspirine use and lung, colon and breast cancer in a prospective study. Epidemiology 5: 138-146
41. Statistisches Jahrbuch der Stadt Basel 1976-1984
42. Suh O, Mettlin CM, Petrelli NJ 1993 Aspirin use, cancer, and polyps of the large bowel. Cancer 72: 1171-1176
43. Takahashi M, Furukawa F, Toyoda K, Sato H, Hasegawa R, Imaida K, Hayashi Y 1990 Effects of various prostaglandine synthesis inhibitors on pancreatic carcinogenesis in hamsters after initiation with N-nitrosobis(2-oxopropyl)amine. Carcinogenesis II: 393-395
44. Thun MJ, Namboodiri M, Heath CW 1991 Aspirin use and reduced risk of colon cancer. N Engl J Med 325: 1393-1396
45. Torhorst J 1973 Nierenscäadigung durch Analgetika. Pathologische Anatomie und Morphogenese. Nephrol Klin Praxis 3: 134-140
46. Trujillo MA, Garewal HS, Sampliner RE 1994 Nonsteroidal antiinflammatory agents in chemoprevention of colorectal cancer: at what cost? Dig Dis Sci 39: 2260-2266
47. Zollinger HU 1955 Chronische interstitielle Nephritis bei Abusus von Phenacetin-haltigen Analgetica (Saridort usw.). Schweiz Med Wschr 85: 746-750
48. Zollinger HU 1960 Schaden bei chronischem Phenacetinabusus. Schweiz Rdsch Med 20: 505-506
49. Zollinger HU 1966 Chronic abuse of phenacetin and kidney lesions. The kidney International Academy of Pathology Monograph 1966, Nr. 6. Williams and Wilkins, Baltimore